Forefront Analytics, LLC
- SEC CIK
- 0001696802
- Latest filing
- Aug 12, 2026
Holdings changes from Q4 2025 to Q1 2026
Long positions only; new, added, reduced and sold out are based on share counts. Pick any two quarters this institution filed.
- New
- 4
- Est. +$1.34M
- Added
- 21
- Est. +$12.2M
- Reduced
- 14
- Est. −$13.0M
- Sold out
- 8
- Est. −$4.81M
Portfolio value went from $113.3M to $110.0M (−$3.31M (−2.9%)); positions from 43 to 39 (−4).
All Q1 2026 holdingsAll Q4 2025 holdings
In the shares, value and % of portfolio columns, the top figure is Q1 2026 and the gray one below is Q4 2025. For stocks that split between the two quarters, Q4 2025 shares are converted at the split ratio before comparing.
| Security | Action | Shares | Share change | Value | Est. bought or sold | % of portfolio | Weight change (pp) |
|---|---|---|---|---|---|---|---|
| MREOMereo BioPharma Group plc | AddedHistory | 127,77831,768 | +96,010+302.2% | $42.2K$13.2K | +$31.7K | <0.1%<0.1% | +0.03 |
| CTMXCytomX Therapeutics, Inc. | ReducedHistory | 12,47618,699 | −6,223−33.3% | $58.6K$79.7K | −$29.2K | 0.1%0.1% | −0.02 |
| BCYCBicycle Therapeutics PLC | AddedHistory | 14,39413,371 | +1,023+7.7% | $66.8K$94.7K | +$4.75K | 0.1%0.1% | −0.02 |
| ANNXAnnexon, Inc. | AddedHistory | 14,24013,226 | +1,014+7.7% | $78.9K$66.4K | +$5.62K | 0.1%0.1% | +0.01 |
| GERNGeron Corp | AddedHistory | 55,12551,320 | +3,805+7.4% | $82.1K$67.7K | +$5.67K | 0.1%0.1% | +0.01 |
| ZURAZura Bio Ltd | ReducedHistory | 14,90119,577 | −4,676−23.9% | $88.7K$102.6K | −$27.8K | 0.1%0.1% | −0.01 |
| NKTXNkarta, Inc. | AddedHistory | 43,83540,702 | +3,133+7.7% | $92.5K$75.3K | +$6.61K | 0.1%0.1% | +0.02 |
| Dimensional ETF Trust25434V815 | New– | 6,3410 | +6,341 | $222.2K$0 | +$222.2K | 0.2%0.0% | +0.20 |
| PMPhilip Morris International Inc. | AddedHistory | 1,4501,437 | +13+0.9% | $239.7K$230.0K | +$2.15K | 0.2%0.2% | +0.01 |
| DHRDanaher Corp | AddedHistory | 1,288915 | +373+40.8% | $244.2K$209.4K | +$70.7K | 0.2%0.2% | +0.04 |
| Vanguard Morningstar Value ETF922908744 | Reduced– | 1,3173,465 | −2,148−62.0% | $258.5K$661.8K | −$421.6K | 0.2%0.6% | −0.35 |
| LEGNLegend Biotech Corp | NewHistory | 15,6590 | +15,659 | $283.3K$0 | +$283.3K | 0.3%0.0% | +0.26 |
| TMOThermo Fisher Scientific Inc. | ReducedHistory | 579586 | −7−1.2% | $284.6K$339.5K | −$3.44K | 0.3%0.3% | −0.04 |
| REGNRegeneron Pharmaceuticals, Inc. | AddedHistory | 460427 | +33+7.7% | $355.0K$329.4K | +$25.5K | 0.3%0.3% | +0.03 |
| OTFBlue Owl Technology Finance Corp. | NewHistory | 29,6540 | +29,654 | $367.4K$0 | +$367.4K | 0.3%0.0% | +0.33 |
| PFEPfizer Inc | ReducedHistory | 13,09019,104 | −6,014−31.5% | $367.6K$475.7K | −$168.9K | 0.3%0.4% | −0.09 |
| ProShares Tr74347R842 | Added– | 7,9907,977 | +13+0.2% | $372.9K$375.1K | +$606.72 | 0.3%0.3% | +0.01 |
| INCYIncyte Corp | ReducedHistory | 4,2335,198 | −965−18.6% | $398.4K$513.4K | −$90.8K | 0.4%0.5% | −0.09 |
| ProShares Tr74347R107 | Added– | 8,1648,146 | +18+0.2% | $423.6K$471.8K | +$933.87 | 0.4%0.4% | −0.03 |
| MDTMedtronic plc | AddedHistory | 5,3194,280 | +1,039+24.3% | $460.9K$411.1K | +$90.0K | 0.4%0.4% | +0.06 |
| Schwab US Dividend Equity ETF808524797 | New– | 15,1190 | +15,119 | $463.9K$0 | +$463.9K | 0.4%0.0% | +0.42 |
| WisdomTree Tr97717W562 | Reduced– | 8,23217,760 | −9,528−53.6% | $477.9K$1.01M | −$553.1K | 0.4%0.9% | −0.46 |
| ABTAbbott Laboratories | AddedHistory | 5,0433,756 | +1,287+34.3% | $517.7K$470.6K | +$132.1K | 0.5%0.4% | +0.06 |
| EWEdwards Lifesciences Corp | AddedHistory | 6,5746,113 | +461+7.5% | $526.4K$521.1K | +$36.9K | 0.5%0.5% | +0.02 |
| UNHUnitedHealth Group Inc | AddedHistory | 1,9831,452 | +531+36.6% | $536.6K$479.2K | +$143.7K | 0.5%0.4% | +0.06 |
| DEDeere & Co | AddedHistory | 1,1361,133 | +3+0.3% | $640.2K$528.0K | +$1.69K | 0.6%0.5% | +0.12 |
| JPMJPMorgan Chase & Co | AddedHistory | 4,9843,353 | +1,631+48.6% | $1.47M$1.08M | +$479.8K | 1.3%1.0% | +0.38 |
| iShares Inc46434G509 | Reduced– | 58,54060,169 | −1,629−2.7% | $2.16M$2.09M | −$60.1K | 2.0%1.8% | +0.12 |
| NVDANVIDIA Corp | AddedHistory | 14,24113,976 | +265+1.9% | $2.48M$2.61M | +$46.2K | 2.3%2.3% | −0.04 |
| iShares Core S&P 500 ETF464287200 | Reduced– | 4,4744,707 | −233−5.0% | $2.92M$3.22M | −$152.2K | 2.7%2.8% | −0.19 |
| Vanguard Ftse Developed Markets ETF921943858 | Reduced– | 47,307123,208 | −75,901−61.6% | $3.03M$7.70M | −$4.86M | 2.8%6.8% | −4.04 |
| iShares MSCI USA Momentum Factor ETF46432F396 | Reduced– | 24,23450,646 | −26,412−52.2% | $5.82M$12.7M | −$6.34M | 5.3%11.2% | −5.90 |
| DBX ETF Tr233051200 | Reduced– | 126,892127,851 | −959−0.8% | $6.27M$6.15M | −$47.4K | 5.7%5.4% | +0.27 |
| Flexshares Tr33939L688 | Added– | 44,23922,999 | +21,240+92.4% | $8.84M$4.72M | +$4.25M | 8.0%4.2% | +3.87 |
| Nushares ETF Tr67092P300 | Added– | 195,657141,379 | +54,278+38.4% | $8.90M$6.37M | +$2.47M | 8.1%5.6% | +2.47 |
| iShares Core High Dividend ETF46429B663 | Reduced– | 68,08769,308 | −1,221−1.8% | $9.24M$8.43M | −$165.7K | 8.4%7.4% | +0.96 |
| Vanguard Ftse Emerging Markets ETF922042858 | Reduced– | 180,162181,105 | −943−0.5% | $9.74M$9.74M | −$51.0K | 8.9%8.6% | +0.26 |
| iShares Inc46434G863 | Added– | 369,453363,728 | +5,725+1.6% | $16.8M$16.1M | +$260.3K | 15.3%14.2% | +1.09 |
| iShares Tr46435G516 | Added– | 254,427211,190 | +43,237+20.5% | $24.3M$20.1M | +$4.13M | 22.1%17.7% | +4.40 |
| iShares Tr464289883 | Sold out– | 058,682 | −58,682−100.0% | $0$2.35M | −$2.35M | 0.0%2.1% | −2.08 |
| First Tr Exchange-Traded FD33738D101 | Sold out– | 018,435 | −18,435−100.0% | $0$698.0K | −$698.0K | 0.0%0.6% | −0.62 |
| iShares Tr464288661 | Sold out– | 04,740 | −4,740−100.0% | $0$566.0K | −$566.0K | 0.0%0.5% | −0.50 |
| iShares Tr464288513 | Sold out– | 03,290 | −3,290−100.0% | $0$265.0K | −$265.0K | 0.0%0.2% | −0.23 |
| iShares Tips Bond ETF464287176 | Sold out– | 02,228 | −2,228−100.0% | $0$245.0K | −$245.0K | 0.0%0.2% | −0.22 |
| iShares Tr464288372 | Sold out– | 03,968 | −3,968−100.0% | $0$244.0K | −$244.0K | 0.0%0.2% | −0.22 |
| iShares Iboxx $ Investment Grade Corporate Bond ETF464287242 | Sold out– | 02,021 | −2,021−100.0% | $0$223.0K | −$223.0K | 0.0%0.2% | −0.20 |
| MIRMMirum Pharmaceuticals, Inc. | Sold outHistory | 02,663 | −2,663−100.0% | $0$210.3K | −$210.3K | 0.0%0.2% | −0.19 |
Estimated amounts multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares): new positions use this quarter's value and sold-out positions last quarter's; positions reported only as principal (PRN) cannot be estimated. 13F shows only quarter-end holdings, not when trades happened or at what price.